Softwr

Research · head to head

LabWare vs PathAI

LabWare logo

LabWare

Research

Enterprise laboratory information management system for regulated labs

From
On request
Rated
-
Full reviewWebsite
PathAI logo

PathAI

Healthcare

Digital pathology image management with an FDA cleared platform for primary diagnosis

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: LabWare implementation and validation take a year or more, and the services cost frequently exceeds the licence; PathAI aISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • They diverge on capability: LabWare covers Sample management, PathAI covers AISight image management.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which LabWare and PathAI actually diverge.

Attributes where LabWare and PathAI differ
AttributeLabWarePathAI
PlatformsWindows, Web, Cloud, On-premiseWeb
CategoryResearchHealthcare

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LabWare

  • Sample management
  • Instrument integration
  • Regulatory compliance
  • Stability studies
  • ELN
  • Configuration framework

Only in PathAI

  • AISight image management
  • AISight Dx
  • Scanner interoperability
  • Case and worklist management
  • AI algorithm deployment
  • Biopharmaceutical research tooling
  • LIS integration

What people use each for

The jobs each tool is most often brought in to do.

LabWare

  • Pharmaceutical quality control laboratories subject to regulatory inspectionnot PathAI
  • Multi-site laboratory networks needing one method and specification librarynot PathAI
  • Contract laboratories managing chain of custody across many clientsnot PathAI
  • Laboratories replacing a validated legacy LIMS they can no longer maintainnot PathAI

PathAI

  • An academic medical centre going digital for primary diagnosis that needs the FDA cleared AISight Dx configuration rather than the research labelled versionnot LabWare
  • A reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any locationnot LabWare
  • A pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readersnot LabWare
  • A laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewernot LabWare

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LabWare

  • Implementation and validation take a year or more, and the services cost frequently exceeds the licence
  • Pricing is entirely quote-based with no public reference point, even by enterprise standards
  • Extensive configuration means the finished system depends heavily on implementation quality, and outcomes vary widely between customers
  • The interface is functional rather than modern, which is a common objection from scientists used to consumer software
  • Substantially over-specified for research laboratories without regulatory obligations

PathAI

  • AISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • The software licence is usually the smallest line in a digital pathology project, behind scanners, storage and network capacity, so a business case built around the software cost understates the real investment by a wide margin.
  • Whole slide images are very large, so a laboratory that does not model storage growth and retention policy from the start faces storage costs that grow faster than case volume and dominate the renewal.
  • Clinical validation is required per subspecialty rather than once for the platform, which means dermatopathology, gastrointestinal and breast each need their own concordance study and pathologist time before go live.
  • PathAI competes against pathology incumbents that also sell the scanners, and a laboratory buying an independent image management layer takes on the integration risk between scanner vendor and software vendor itself.

Pricing, plan by plan

LabWare

On request
  • LabWare LIMS$undefined/year
    • Sample management
    • Instrument integration
    • Regulatory compliance

PathAI

On request
  • AISight$undefined/year
    • Priced by annual slide or case volume and by pathologist seats
    • AISight Dx, the clinically cleared configuration, quoted separately from research use AISight
    • Image storage priced by capacity and retention policy

Which should you pick?

Choose LabWare if

  • You need sample management.
  • You work on Windows, Web, Cloud, On-premise.
  • You also want instrument integration.
LabWare review

Choose PathAI if

  • You need aisight image management.
  • You also want aisight dx.
PathAI review

Questions people ask

Is LabWare or PathAI better?
Neither clearly leads. LabWare starts at On request and PathAI at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LabWare or PathAI?
LabWare starts at On request and PathAI at On request.
Does LabWare or PathAI run on more platforms?
LabWare runs on Windows, Web, Cloud, On-premise. PathAI runs on Web.
What is LabWare best used for?
LabWare is most often used for pharmaceutical quality control laboratories subject to regulatory inspection, multi-site laboratory networks needing one method and specification library, contract laboratories managing chain of custody across many clients, laboratories replacing a validated legacy lims they can no longer maintain. Of those, pharmaceutical quality control laboratories subject to regulatory inspection and multi-site laboratory networks needing one method and specification library are not what PathAI is typically brought in for.
What can LabWare do that PathAI cannot?
LabWare covers Sample management, Instrument integration, Regulatory compliance, Stability studies. PathAI covers AISight image management, AISight Dx, Scanner interoperability, Case and worklist management.

Answered from the vendors’ own pages

LabWare: Why is LabWare so dominant in pharma?

Validation experience. In a regulated laboratory the software forms part of what an inspector examines, and decades of accumulated validation practice is not something a newer vendor can substitute for.

PathAI: What is the difference between AISight and AISight Dx?

AISight is for research use only and not for clinical diagnostic use. AISight Dx received FDA 510(k) clearance in June 2025 for primary diagnosis and is CE-IVD marked in the EEA, UK and Switzerland. Only the Dx configuration can be used to sign out cases.

LabWare: What does it cost?

Not published. Enterprise licensing plus implementation and validation services, and the services frequently exceed the licence.

PathAI: Can we use our existing scanners?

Yes. AISight is designed to ingest images from multiple whole slide scanner vendors, which is one of the main reasons laboratories choose an independent image management layer.

LabWare: How long is implementation?

A year or more for a regulated laboratory, including validation. Anyone quoting substantially less is either scoping narrowly or omitting validation.

PathAI: Do the AI algorithms carry the same clearance as the platform?

No. The platform clearance covers image management for primary diagnosis. Individual algorithms have their own labelling, and many are research use only. Check each one separately.

LabWare: Does it include an electronic laboratory notebook?

Yes, LabWare offers ELN alongside LIMS on the same platform, which avoids the integration problem of running two vendors.

PathAI: Is pricing published?

No. It is quoted by slide or case volume, pathologist seats and storage, with the clinically cleared configuration priced separately.

LabWare: Is it suitable for a research lab?

Usually not. Research laboratories without regulatory obligations pay for compliance machinery they do not need, and Benchling or a lighter LIMS fits better.

Share

Related pages

More on LabWare

More on PathAI

Keep looking

Other head to heads